Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease

NCT: NCT07605624 · NOT_YET_RECRUITING

NCT IDNCT07605624
StatusNOT_YET_RECRUITING
Start Date2026-05-10
Completion2029-01-31
SponsorBeijing Anzhen Hospital (OTHER)
First posted
Last updated

Brief Summary

This prospective, multicenter, observational cohort study aims to establish a post-market registry framework to evaluate the real-world clinical applicability, long-term safety, and effectiveness of innovative heart valve devices in China.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑